Paper Details

  1. Home
  2. Paper Details

Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.

Author: FujiedaShigeharu, KimuraYuichi, KuboSeita, OhMyonmi, OkamotoMasayuki, OsawaYoko, SusukiDai, TakabayashiTetsuji, YamadaTakechiyo, YamamotoHideyuki

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Oral olopatadine effectively controlled nasal allergy symptoms in patients with seasonal allergic rhinitis, particularly nasal congestion. It also improved quality of life and had no significant adverse effects.
Paper Details　
Original Abstract of the Article :
Adequate treatment is critical for maintaining a good level of quality of life (QOL) during the pollen season in patients suffering from seasonal allergic rhinitis (SAR). Olopatadine, a histamine H(1)-receptor antagonist, has been approved in the United States and Europe for the treatment of AR and ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.2500/aap.2010.31.3355

データ提供：米国国立医学図書館（NLM）

Olopatadine: A Relief for Seasonal Allergies

Seasonal allergies, often triggered by pollen, can make life miserable during certain times of the year. This study investigates the efficacy of oral olopatadine, an antihistamine, for treating seasonal allergic rhinitis. Imagine olopatadine as a cool desert oasis providing respite from the pollen storm. Researchers conducted a randomized, double-blind, placebo-controlled study to evaluate the effectiveness of oral olopatadine in reducing allergic symptoms.

Easing the Burden of Allergies

The study found that oral olopatadine effectively reduced sneezing, runny nose, and nasal congestion in patients with seasonal allergies, demonstrating its potential as a viable treatment option.

Managing Seasonal Allergies

If you suffer from seasonal allergies, it's important to consult with an allergist or physician to discuss treatment options, which may include antihistamines, nasal corticosteroids, and immunotherapy.

Dr.Camel's Conclusion

Seasonal allergies, like a desert dust storm, can make life uncomfortable. This study offers a glimmer of hope, suggesting that oral olopatadine could provide a much-needed oasis of relief for those suffering from seasonal allergic rhinitis.

Date :
  1. Date Completed 2011-06-14
  2. Date Revised 2016-10-20
Further Info :

Pubmed ID

20819319

DOI: Digital Object Identifier

10.2500/aap.2010.31.3355

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.